Mafenide Acetate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Mafenide Acetate is used to treat bacterial infections and wound infection, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Feb 12, 2013. In 2024, Medicare Part D spent $51K on Mafenide Acetate across 447 claims for 297 beneficiaries.
Mafenide Acetate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $1.23 to $1.23 per GM. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$1.23 – $1.23
per GM
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
1 manufacturer producing MAFENIDE ACETATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
SULFAMYLON 8.5% CREAM | $1.2343 per GM | — |
Frequently Asked Questions
What is Mafenide Acetate used to treat?
Mafenide Acetate is used to treat bacterial infections and wound infection, per the National Library of Medicine's MED-RT classification.
When did Mafenide Acetate become available as a generic?
FDA approved the first generic Mafenide Acetate (ANDA) on Feb 12, 2013.
How much does Medicare spend on Mafenide Acetate?
In 2024, Medicare Part D spent $51K on Mafenide Acetate across 447 claims for 297 beneficiaries.
How many Mafenide Acetate products are on the market?
The Mafenide Acetate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Mafenide Acetate?
NADAC reference prices for Mafenide Acetate range from $1.2343 to $1.2343 per GM.
Which manufacturers make Mafenide Acetate?
1 manufacturer lists Mafenide Acetate in NADAC. Ranked by number of NDCs, the largest are Rising Pharma Holdings Inc. (1).